Lowenstein Sandler announced Wednesday that veteran dealmaker Ivan Presant has joined the firm as a partner in its Transactions & Advisory Group. Based in the firm’s New York City office, Presant brings over three decades of experience navigating high-stakes domestic and cross-border mergers and acquisitions.
The move comes as Lowenstein continues to execute its “Vision 2030 Strategic Plan,” an initiative aimed at scaling the firm’s market-leading practices to meet sustained demand in the global deal-making environment.
Presant’s practice is noted for its breadth, representing both public and private entities across a diverse array of industries, including:
- Life Sciences & Health Care: Advising on pharmaceutical licensing and health care acquisitions.
- Fintech & Financial Services: Navigating regulatory and structural complexities in the financial sector.
- Retail, Food & Beverage: Managing brand-heavy transactions and joint ventures.
His expertise spans the full lifecycle of corporate evolution, from initial joint ventures and licensing to complex recapitalizations, tender offers, and corporate control matters.
“Ivan’s experience across complex, high-value transactions aligns directly with our strategy and positions us well for continued growth,” Jonathan Wishnia, Lowenstein’s managing partner said.
Jeffrey Shapiro, chair of Lowenstein’s Transactions & Advisory Group, highlighted Presant’s versatility. “His experience across public and private deals, including tender offers and proxy contests, complements our existing capabilities and enhances the range of matters we can handle,” Shapiro noted.
Presant, who joins the firm from Mintz, cited Lowenstein’s unique market position as a primary draw. “Lowenstein has built a premier transactional platform that combines sophisticated deal capability with a collaborative, client-first culture,” he said.
Marita Makinen, chair of the firm’s M&A practice, emphasized that Presant’s arrival strengthens the firm’s ability to assist clients in an “increasingly dynamic deal environment,” particularly those involving cross-border complexities and non-bankruptcy restructurings.
